FDA approves Seattle Genetics cancer drug

WASHINGTON (Reuters) - Drug regulators gave the go ahead on Friday for a blood cancer medicine by Seattle Genetics Inc, making it the first drug for Hodgkin's lymphoma approved in more than 30 years.

doctor oz